Google Ads Policy for Peptides in 2026: What’s Allowed and What’s Banned

For research-use-only (RUO) peptide sellers · 2026 Google Ads policy

Google Ads policy for peptides is where most RUO brands get burned — not because peptides can’t be advertised, but because the line between “allowed” and “banned” is a single word in your ad copy. At iComChain we run compliant peptide campaigns every day. Here is exactly what Google permits and prohibits in 2026, so you can advertise without losing your account.

Google Ads is one rulebook among several — the 2026 peptide policy map shows how the others connect.

How Google classifies peptides

Peptides — BPC-157, TB-500, sermorelin, ipamorelin, CJC-1295 and the rest — sit at the intersection of three Google Ads policies: healthcare and medicines, unapproved pharmaceuticals and supplements, and restricted drug terms. Google treats them as a high-risk category because they’re so often marketed with healing, recovery, hormone or performance claims. That classification — not the molecule itself — decides whether your ad runs.

What’s allowed (with conditions)

These are permitted in 2026, provided every condition is met:

• Research-use-only (RUO) peptides advertised strictly for laboratory research, with a clear “For research use only. Not for human consumption.” disclaimer in the ad and on the landing page.
• Scientific, factual product information — compound name, purity, quantity and format — with no human-use framing.
• Ads from verified advertisers who have completed Google’s advertiser identity verification and, where required, the Healthcare and Medicines certification.
• Restricted / prescription drug terms (only) when the advertiser is LegitScript certified and only where the policy permits it.
• Bulk / lab supply of peptides and compounds to commercial labs — in select locations only, by advertisers who have applied and been approved.
• Landing pages that match the ad and carry the same RUO language and consistent pricing/availability.

What’s banned outright

These get ads disapproved and accounts suspended, regardless of geography or how you phrase them:

• Any human-use claim — dosage for a person, “results,” recovery, anti-ageing, muscle, performance, hormone or condition benefits.
• Selling or promoting peptides for human consumption in ad copy or on the landing page.
• Speculative or experimental treatment framing — Google prohibits ads for speculative/experimental medical treatments and unapproved, unsafe or deceptive treatments.
• Unsubstantiated health claims of any kind.
• Prescription / restricted drug names (for example semaglutide or GLP-1 terms) in ad copy without LegitScript certification.
• Before/after imagery or body/physique visuals that imply human use.
• Misrepresentation — ad, landing page and feed that don’t match on claims, price or availability.

The molecule is rarely the problem. The claim is. “BPC-157 5mg, 99% purity, for research use only” can run; “BPC-157 for faster injury recovery” cannot.

The certification gate

Three approvals govern whether you can advertise:

• Advertiser identity verification — required for essentially all advertisers; non-negotiable for healthcare-adjacent products.
• Healthcare and Medicines certification — required for many healthcare-related advertisers before ads can run.
• LegitScript certification — the gate for restricted drug terms and, increasingly, the practical requirement to run and to keep payment processors comfortable.

Certification also interacts with geography: some healthcare content can only be advertised in certain locations, by approved advertisers, and some is prohibited everywhere.

Compliant ad copy & landing pages

The rule of thumb: describe the product like a lab-supply catalogue, never like a supplement or medicine.

Do: lead with compound, strength, purity and format; keep everything scientific; include the RUO disclaimer; match the landing page to the ad exactly.

Don’t: mention dosing for people, benefits, conditions, recovery or performance; use ALL CAPS or hype; name restricted drugs without LegitScript; or send clicks to a page that implies human use.

What triggers a suspension

Across the accounts iComChain has rescued, the same triggers recur: human-use or benefit language, a landing page that contradicts the ad, restricted drug terms without certification, unverified advertiser identity, and repeated disapprovals ignored rather than fixed. Fix the wording and the consistency, and peptide ads are far more durable than most sellers believe.

Compliant peptide advertising isn’t about tricking Google. It’s about presenting a research product so clearly and honestly that there’s nothing left to flag.

Frequently asked questions

Related peptide compliance guides

For research-use-only (RUO) products intended for laboratory research only — not for human consumption. This is general information, not legal advice; always confirm against Google’s current healthcare and medicines and unapproved substances policies. iComChain provides marketing and compliance services and is not affiliated with or endorsed by Google.